UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 11, 2016 (October 10, 2016)

  

 

 

GLOBAL MEDICAL REIT INC.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland 8091371022 46-4757266

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

     
 

4800 Montgomery Lane, Suite 450

Bethesda, MD

20814

 
 

(Address of Principal Executive Offices)

(Zip Code)

 
     
  (202) 524-6851  
(Registrant’s Telephone Number, Including Area Code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 

  

ITEM 8.01.  OTHER EVENTS.

   

Announcement of Property Acquisitions

 

On October 10, 2016, Global Medical REIT Inc. (the “Company”) announced that it has closed multiple acquisitions, which the Company previously announced on a Form 8-K filed with the Securities and Exchange Commission on September 15, 2016. In the previously announced Form 8-K, the Company announced the planned closing of three separate transactions for an aggregate price of $30,860,000 covering eleven buildings in total. The three projects are the “Brown Clinic” in Watertown, SD; the “Northern Ohio Medical Specialists (NOMS)” portfolio in Northern Ohio; and the “Prospect Medical Office Building” in East Orange, NJ. The Company has closed the acquisition of nine of the buildings for a total purchase price of $25,439,200 and expects to close the remaining two buildings for the remaining $5,420,800 in December following completion of certain renovations that are currently in process and satisfaction of customary closing conditions.

  

A copy of the closing press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

 

Forward-Looking Statements

 

This report contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. These statements relate to, among other things, the Company’s expectations regarding the completion of the acquisitions described in this report on the terms and conditions described herein and the expected closing dates of these acquisitions. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. These risks and uncertainties are described in greater detail in the Company’s other filings with the Securities and Exchange Commission (the “Commission”), including without limitation the Company’s annual and periodic reports and other documents filed with the Commission. Unless legally required, the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The Company undertakes no obligation to update these statements after the date of this report.

 

The information in Exhibit 99.1 referenced in Item 9.01 below is being “furnished” and, as such, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document filed by the Company pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

(d)Exhibits

 

Exhibit No.   Description
99.1   Press release dated October 10, 2016.

  

 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  GLOBAL MEDICAL REIT INC.
     
     
  By: /s/ Conn Flanigan
    Conn Flanigan
    Secretary and General Counsel

 

Dated: October 11, 2016

  

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Press release dated October 10, 2016.